Celecoxib → Methyl N-(2-Methoxy-2-oxoethl)-N-({4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}sulfonyl)glycinate

HRID 393860

反応式

HRID 393860 の反応式
[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[N:12]([C:13]3[CH:14]=[CH:15][C:16]([S:19]([NH2:22])(=[O:21])=[O:20])=[CH:17][CH:18]=3)[N:11]=[C:10]([C:23]([F:26])([F:25])[F:24])[CH:9]=2)=[CH:6][CH:7]=1.Br[CH2:28][C:29]([O:31][CH3:32])=[O:30].[C:33]([O-:36])([O-])=O.[K+].[K+].[C:39]([O-])(O)=O.[Na+].CN([CH:47]=[O:48])C>>[CH3:32][O:31][C:29](=[O:30])[CH2:28][N:22]([S:19]([C:16]1[CH:15]=[CH:14][C:13]([N:12]2[C:8]([C:5]3[CH:6]=[CH:7][C:2]([CH3:1])=[CH:3][CH:4]=3)=[CH:9][C:10]([C:23]([F:24])([F:26])[F:25])=[N:11]2)=[CH:18][CH:17]=1)(=[O:21])=[O:20])[CH2:39][C:33]([O:48][CH3:47])=[O:36]

参加物

6

実験手順

A mixture of Celecoxib (0.500 g, 1.31 mmol), methyl bromoacetate (0.501 g, 3.28 mmol) and K2CO3 (0.362 g, 2.62 mmol) in anhydrous DMF (5.0 mL) was stirred at room temperature for 21 hours. The mixture was then poured into sat. NaHCO3 (200 mL) and extracted with ethyl acetate (200 mL). The ethyl acetate solution was then washed with sat NaCl (50 mL), dried over MgSO4, filtered and concentrated under vacuum. The crude product was purified by flash chromatography (silica gel, 98:2 methylene chloride:methanol) to afford 0.350 g (51% yield) of the product as a colorless glass: 1H NMR (dmso-d6/300 MHz) δ 7.90 (d, 2H, J=8.7 Hz), 7.53 (d, 2H, J=8.7 Hz), 7.23-7.17 (m, 5H), 4.19 (s, 4H), 3.54 (s, 6H), 2.30 (s, 31H); HRMS (M+NH4)+ calcd. for C23H26F3N4O6S: 543.1525; found: 543.1526.

後処理

  1. extractionextracted with ethyl acetate (200 mL)
  2. washThe ethyl acetate solution was then washed with sat NaCl (50 mL)
  3. dry with materialdried over MgSO4
  4. filtrationfiltered
  5. concentrationconcentrated under vacuum
  6. customThe crude product was purified by flash chromatography (silica gel, 98:2 methylene chloride:methanol)

出典と根拠

ORDレコード
ord-e819c016cfd94453b1fd6abf05e5e7ab
出典データセット
uspto-grants-2004_10
特許番号
US06809111B2

関連ノート

読み込み中…